2 results
Approved WMORecruiting
To assess the feasibility and efficacy of 90Y-ibritumomab tiuxetan consolidation treatment after R-PECC chemotherapy as second or third line treatment in patients with refractory or relapsed aggressive B-cell NHL, after or not eligible for…
Approved WMOCompleted
Primary Objective: The primary objective of this study is to assess the efficacy of computer controlled cooling on postoperative pain in rest in the first 7 days of recovery, measured with the NRS score. Secondary Objectives: * Assess the effect of…